Clinical Trial 47307

Delray Beach, FL 33484


Summary:

<b>Atopic Dermatitis (Eczema) - Multiple Locations in the US</b>

    Eczema Study for Kids and Adults: The ADORING study is evaluating an investigational non-steroidal topical cream for people aged 2 years and older who suffer from moderate to severe eczema, also known as atopic dermatitis (AD).

    ADORING is a phase 3 clinical study evaluating the safety and efficacy of tapinarof cream, 1% for the topical treatment of moderate to severe eczema in adults and children aged 2 years and above.

    ADORING at a Glance

    • Participants: up to 400 adults and children
    • Duration: up to 13 weeks
    • Administration: daily self-application of cream

    People who may be eligible:*

    • Been diagnosed with eczema
      • for at least 6 months for those 6 years old and above or
      • 3 months for those 2 to 5 years old
    • Male or female, 2 years of age or older
    • Have eczema that covers between 5% and 35% of their body, not including the scalp. NOTE: Participants with eczema only on their palms and soles are not eligible.

    *Other criteria will apply


    Available At:

    To learn more and find out if you or your child may be eligible, please CLICK HERE.

    To view an updated list of participating research sites click
    here.

     


    Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.